Health

Results: 4153-4164 of 8799

Society for Clinical Research Sites (SCRS) and Fortrea Partner to Advance Collaboration in Clinical Research

Variational AI Announces Oversubscribed $5.5 Million Financing to Launch Foundation Model for Small Molecule Drug Discovery

Oncoinvent ASA: Invitation to Result Presentation Q4 2024

Hologic Obtains CE Mark for Affirm® Contrast Biopsy Software

DIA Europe 2025 to Address EU Regulatory Reforms and How to Advance Global Healthcare Harmonization

PR Newswire associated0

NEW PERSIL RESEARCH REVEALS THAT OVER 75% OF TEENAGE GIRLS HAVE STOPPED PLAYING SPORTS DUE TO THEIR PERIOD

BioArctic's global license agreement with Bristol Myers Squibb for PyroGlutamate-amyloid-beta antibody program effective after antitrust clearance and closing

NaviFUS Corp. Advances Non-Invasive Precision Medicine for Brain Disorders with Taiwan's Chip Technology

ICON Reports Fourth Quarter and Full Year 2024 Results

GlobeNewswire associated0

KFSHRC Performs Groundbreaking Procedure to Save Child’s Leg from Amputation

Parse Biosciences Launches 5 Million Cell Evercode WT Penta Kit for Single Cell Sequencing

Set to complete in 2027, the state-of-the-art iREACH Health clinical research center is set to become a cornerstone of Northern Ireland's life sciences landscape. As part of this development, Celerion will relocate its U.K. Phase 1 clinical research operations to the facility, positioning it at the forefront of clinical research innovation. (Photo: Business Wire)

Celerion Expands UK Phase 1 Clinical Research Operations With New Agreement to Relocate to Queen’s University Belfast’s iREACH Health – Clinical Research Innovation Center